Health Counterfeit 'reta' jabs flood UK market as experimental weight‑loss drug remains unapproved Deborah Osei · September 5, 2026
Technology Pharma manufacturing and AI risks take centre stage as companies bet on capacity and sustainability Sanjay Bhatt · August 14, 2026
Business Eledon cleared to start global Phase 3 for tegoprubart as cash sits at $88.8m Marcus Adeyemi · August 14, 2026
Business Lakefront confirms ~€2bn year‑end cash, completes Ouro Medicines deal with Gilead Marcus Adeyemi · August 10, 2026
Health
